Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Plant

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Journal of Immunology Research|September 7, 2018
Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid ArthritisSrikant Ambatipudi, Gemma C Sharp, Sarah L N Clarke, et al.
Pharmacogenomics|May 17, 2016
Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Xiu Hue Lee, et al.
Annals of the Rheumatic Diseases|March 4, 2011
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritisBenjamin A Fisher, Darren Plant, Monica Brode, et al.
Arthritis Research & Therapy|March 11, 2021
Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatmentJames Oliver, Nisha Nair, Gisela Orozco, et al.
Arthritis Research & Therapy|May 9, 2021
Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatmentJames Oliver, Nisha Nair, Gisela Orozco, et al.
Rheumatology (Oxford, England)|September 13, 2014
Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJames Bluett, Catharine Morgan, Layla Thurston, et al.
Annals of the Rheumatic Diseases|November 18, 2023
Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcomeKatriona Goldmann, Athina Spiliopoulou, Andrii Iakovliev, et al.
Arthritis Research & Therapy|October 9, 2012
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortDarren Plant, Ibrahim Ibrahim, Mark Lunt, et al.
Arthritis Care & Research|December 17, 2013
Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritisLis Cordingley, Rita Prajapati, Darren Plant, et al.
Rheumatology (Oxford, England)|October 3, 2022
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan M Hum, Pauline Ho, Nisha Nair, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Journal of Immunology Research|September 7, 2018
Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid ArthritisSrikant Ambatipudi, Gemma C Sharp, Sarah L N Clarke, et al.
Pharmacogenomics|May 17, 2016
Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Xiu Hue Lee, et al.
Annals of the Rheumatic Diseases|March 4, 2011
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritisBenjamin A Fisher, Darren Plant, Monica Brode, et al.
Arthritis Research & Therapy|March 11, 2021
Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatmentJames Oliver, Nisha Nair, Gisela Orozco, et al.
Arthritis Research & Therapy|May 9, 2021
Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatmentJames Oliver, Nisha Nair, Gisela Orozco, et al.
Rheumatology (Oxford, England)|September 13, 2014
Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJames Bluett, Catharine Morgan, Layla Thurston, et al.
Annals of the Rheumatic Diseases|November 18, 2023
Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcomeKatriona Goldmann, Athina Spiliopoulou, Andrii Iakovliev, et al.
Arthritis Research & Therapy|October 9, 2012
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortDarren Plant, Ibrahim Ibrahim, Mark Lunt, et al.
Arthritis Care & Research|December 17, 2013
Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritisLis Cordingley, Rita Prajapati, Darren Plant, et al.
Rheumatology (Oxford, England)|October 3, 2022
Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritisRyan M Hum, Pauline Ho, Nisha Nair, et al.
Pageof 11